Victorio Bambini-Junior Selected Research

Valproic Acid (Depakote)

12/2023	Preventive effects of resveratrol against early-life impairments in the animal model of autism induced by valproic acid.
1/2020	Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism.
1/2019	Abnormal empathy-like pro-social behaviour in the valproic acid model of autism spectrum disorder.
6/2018	Data on social transmission of food preference in a model of autism induced by valproic acid and translational analysis of circulating microRNA.
5/2018	Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.
1/2018	Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid.
1/2018	Reduced CD4 T Lymphocytes in Lymph Nodes of the Mouse Model of Autism Induced by Valproic Acid.
1/2015	Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
11/2014	Resveratrol prevents social deficits in animal model of autism induced by valproic acid.
2/2013	Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victorio Bambini-Junior Research Topics

Disease

15	Autistic Disorder (Autism) 12/2023 - 07/2008
7	Autism Spectrum Disorder 01/2022 - 11/2014
2	Brain Diseases (Brain Disorder) 03/2024 - 01/2015
2	Brain Edema (Cerebral Edema) 11/2021 - 01/2013
1	Inflammation (Inflammations) 03/2024
1	Brain Ischemia (Cerebral Ischemia) 03/2024
1	Edema (Dropsy) 11/2021
1	Mental Disorders (Mental Disorder) 11/2021
1	Infectious Pregnancy Complications 02/2021
1	Sepsis (Septicemia) 02/2021
1	Neurodevelopmental Disorders 05/2018
1	Neoplasms (Cancer) 07/2016
1	Medulloblastoma 07/2016
1	Brain Neoplasms (Brain Tumor) 07/2016
1	Cognitive Dysfunction 01/2015
1	Hypoxia (Hypoxemia) 01/2013
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2013
1	Glioma (Gliomas) 07/2008

Drug/Important Bio-Agent (IBA)

11	Valproic Acid (Depakote)FDA LinkGeneric 12/2023 - 08/2011
4	ResveratrolIBA 12/2023 - 11/2014
2	Bumetanide (Bumex)FDA LinkGeneric 01/2022 - 10/2014
2	Aquaporins (Water Channels)IBA 11/2021 - 01/2013
2	MicroRNAs (MicroRNA)IBA 06/2018 - 05/2018
2	Circulating MicroRNAIBA 06/2018 - 05/2018
2	AntioxidantsIBA 05/2018 - 11/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2024
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Aquaporin 1IBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	ParvalbuminsIBA 10/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2021
1	CalbindinsIBA 10/2021
1	Saline SolutionIBA 02/2021
1	Meropenem (Merrem)FDA LinkGeneric 02/2021
1	CytokinesIBA 02/2021
1	SolutionsIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 02/2021
1	Suramin (Suramin Sodium)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 06/2018
1	Small Untranslated RNAIBA 05/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2016
1	TropomyosinIBA 07/2016
1	Phosphotransferases (Kinase)IBA 07/2016
1	Histamine Receptors (Histamine Receptor)IBA 01/2015
1	LigandsIBA 01/2015
1	ciproxifanIBA 01/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 10/2014
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2014
1	gamma-Aminobutyric Acid (GABA)IBA 10/2014
1	Glutamic Acid (Glutamate)FDA Link 02/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2013
1	Oxygen (Dioxygen)IBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Risperidone (Risperdal Consta)FDA LinkGeneric 07/2008
1	Antipsychotic Agents (Antipsychotics)IBA 07/2008

Therapy/Procedure

1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 01/2018